• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, September 10, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Tasmanian devil cancer unlikely to cause extinction, say experts

Bioengineer by Bioengineer
January 24, 2019
in Cancer
Reading Time: 3 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: Dr Rodrigo Hamede

A new study of Tasmanian devils has revealed that a transmissible cancer which has devastated devil populations in recent years in unlikely to cause extinction of the iconic species.

New research led by Dr Konstans Wells from Swansea University has revealed that it is more likely that the disease will fade-out or that the devils will coexist with Tasmanian Devil Facial Tumour Disease (DFTD) in future.

DFTD typically kills the majority of devils it infects and has wiped out around 80% of wild devils with continuous decline of existing populations since the disease was first identified.

An international team of scientists from the UK, Australia and the USA matched field epidemiological evidence from wild populations collected over a 10-year period in north-west Tasmania with simulation studies, which revealed that DFTD is unlikely to continue causing ongoing population declines of Tasmanian devils in future.

They say the findings of their study, published in Ecology, offers much-needed hope that the species, which is the world’s largest remaining marsupial carnivore, will not necessarily become extinct due to DFTD.

First discovered in north-eastern Tasmania in 1996, DFTD causes tumours to form on the face and neck of the animal. The cancer spreads when the devils bite each other’s faces during fighting, thus killing the animals within six to twenty four months.

Dr Konstans Wells, lead author of the study, said: “Our findings suggest that immediate management interventions are unlikely to be necessary to ensure the survival of Tasmanian devil populations. This is because strong population declines of devils after disease emergence do not necessarily translate into long-term population declines”.

To explore the long-term outcomes of DFTD and devil populations, the researchers conducted a large number of simulations of possible disease spread in devils. Based on evidence such as current infection rates in the wild, the most likely simulation scenarios were selected to explore how DFTD will affect devil populations over the next 100 years. Among the most likely scenarios were those in which DFTD faded out (57% of likely scenarios) or coexisted with devils (22% of likely scenarios).

Co-author of the study, Dr Rodrigo Hamede from the University of Tasmania, said: “With growing evidence that devils are showing signs of adaptation to DFTD and that so far the disease has not caused local extinctions, management actions targeted at understanding the devil’s adaptive strategies to cope with DFTD should be considered.

“Complete eradication of DFTD is not feasible, therefore studying the long-term interactions between devils and tumours will provide a realistic prognosis for the species and at the same time will help us to understand important evolutionary processes. This is particularly relevant given the recent outbreak of a new transmissible cancer – devil facial tumour 2 – affecting devil populations in south-eastern Tasmania. Devils seem to be prone to transmissible cancers, so studying epidemic dynamics and evolutionary responses to this type of diseases should be a priority”.

The research suggests that management efforts to maintain devil populations should be guided by the changing understanding of the long-term outcome of the disease impact on devils.

Dr Wells explained: “Management efforts in wild populations that solely aim to combat the impact of DFTD can be counterproductive if they disrupt long-term forces at work that may eventually lead to stable devil populations that are well able to persist with the cancer.

“Wildlife diseases such as DFTD should not disguise the fact that sufficiently large and undisturbed natural environments are a vital prerequisite for wildlife to persist and eventually cope with obstructions such as infectious diseases without human intervention”.

The study Individual and temporal variation in pathogen load predicts long-term impacts of an emerging infectious disease is published in Ecology.

###

Media Contact
Catrin Newman
[email protected]
01-792-513-454

Tags: BiologycancerCell BiologyDeath/DyingEvolutionResearch/Development
Share14Tweet9Share2ShareShareShare2

Related Posts

Misconceptions Prevent Certain Cancer Patients from Accessing Hormone Therapy Benefits

Misconceptions Prevent Certain Cancer Patients from Accessing Hormone Therapy Benefits

September 10, 2025

Scientists Discover Giant DNA Hidden Within the Human Mouth

September 10, 2025

Sociodemographics Affect Quality of Life Post-Prostatectomy

September 10, 2025

Blood Test Detects HPV-Linked Head and Neck Cancers Up to a Decade Before Symptoms Appear

September 10, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    151 shares
    Share 60 Tweet 38
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    116 shares
    Share 46 Tweet 29
  • Physicists Develop Visible Time Crystal for the First Time

    52 shares
    Share 21 Tweet 13
  • First Confirmed Human Mpox Clade Ib Case China

    56 shares
    Share 22 Tweet 14

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Critically Endangered Shark Meat Frequently Sold Under False Labels in US, Study Finds

Misconceptions Prevent Certain Cancer Patients from Accessing Hormone Therapy Benefits

New ECU Study Reveals Muscle Loss in Children During Early Cancer Treatment: A Hidden Threat to Recovery

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.